Your browser doesn't support javascript.
loading
Mortality from cystic fibrosis in Europe: 1994-2010.
Quintana-Gallego, Esther; Ruiz-Ramos, Miguel; Delgado-Pecellin, Isabel; Calero, Carmen; Soriano, Joan B; Lopez-Campos, Jose Luis.
Afiliación
  • Quintana-Gallego E; Unidad de Fibrosis Quística, Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/Universidad de Sevilla, Sevilla, Spain.
  • Ruiz-Ramos M; CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
  • Delgado-Pecellin I; Consejería de Igualdad, Salud y Políticas Sociales de Andalucía, Seville, Spain.
  • Calero C; Unidad de Fibrosis Quística, Servicio de Pediatría, Hospital Universitario Virgen del Rocio, Seville, Spain.
  • Soriano JB; Unidad de Fibrosis Quística, Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/Universidad de Sevilla, Sevilla, Spain.
  • Lopez-Campos JL; CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Pediatr Pulmonol ; 51(2): 133-42, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26584153
ABSTRACT

OBJECTIVE:

To date, available mortality trends due to cystic fibrosis (CF) have been limited to the analysis of certain countries in different parts of the world showing that mortality trends have been constantly decreasing. However, no studies have examined Europe as a whole. The present study aims to analyze CF mortality trends by gender within the European Union (EU) and to quantify potential years of life lost (PYLL).

DESIGN:

Deaths from the 27 EU countries were obtained from the statistical office of the EU from the years 1994-2010. Crude and age-standardized mortality rates (ASR) were estimated for women and men using the standard European population, expressed in deaths per 1,000,000 persons. The PYLL from ages 0 up to 30 years were estimated. Trends were studied by a joinpoint regression analysis.

RESULTS:

During the study period, 5,130 deaths (2,443 in males and 2,687 in females) were identified. Females had a slightly higher mortality rate than males, with a downward trend observed for both genders. In males, the ASR changed from 1.34 in 1994 to 1.03 in 2010. In females, the ASR changed from 1.42 in 1994 to 0.92 in 2010. The mean age at death and PYLL increased for both genders. The joinpoint analysis did not identify any significant joinpoint for either gender for ASR or PYLL.

CONCLUSIONS:

Our data suggest a continued downward trend of CF mortality throughout the EU, with differences by country and gender.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fibrosis Quística Tipo de estudio: Observational_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Europa Idioma: En Revista: Pediatr Pulmonol Asunto de la revista: PEDIATRIA Año: 2016 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fibrosis Quística Tipo de estudio: Observational_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Europa Idioma: En Revista: Pediatr Pulmonol Asunto de la revista: PEDIATRIA Año: 2016 Tipo del documento: Article País de afiliación: España